机构:[1]Department of Gastroenterology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[2]Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China四川大学华西医院[3]Dpartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院
We thank the members of the CC-LY laboratory for their technical support and
suggestions, and the Core Facilities of West China Hospital. This work was supported
by the National Key R&D Program of China (2017YFA0505600), the National Natural
Science Foundation of China (81522003, 82170171, 81770157, and 82003156), the
Sichuan Science and Technology Program (2020YFQ0059, 2018JZ0077,
2017TJPT0005, 2022YFS0171 and 2022YFS0205), 1.3.5. Project for Disciplines of
Excellence, West China Hospital, Sichuan University, and the innovation initiative of
Sichuan University, Grant no. 2018SCUH0060. We thank the Chengdu OrganoidMed
Medical Laboratory for their technical support. We also thank BioRender (biorender.
com) for providing items for drawing scheme graphs.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
最新[2023]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
第一作者:
第一作者机构:[1]Department of Gastroenterology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Pan Xiangyu,Wang Jian,Guo Linjie,et al.Identifying a confused cell identity for esophageal squamous cell carcinoma.[J].Signal transduction and targeted therapy.2022,7(1):122.doi:10.1038/s41392-022-00946-8.
APA:
Pan Xiangyu,Wang Jian,Guo Linjie,Na Feifei,Du Jiajia...&Chen Chong.(2022).Identifying a confused cell identity for esophageal squamous cell carcinoma..Signal transduction and targeted therapy,7,(1)
MLA:
Pan Xiangyu,et al."Identifying a confused cell identity for esophageal squamous cell carcinoma.".Signal transduction and targeted therapy 7..1(2022):122